Skip to main content

Table 3 Binding affinity (Kd), structure, and inhibitors of the critical PPIs involving MLL1 fusion proteins

From: Structure, function and inhibition of critical protein–protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins

PPIs

Kd (μM)

Structures (PDB)

Inhibitors

AFF4-ELL2

0.086 [190]

5JW9 [190]

None

AFF4-Cyclin T1

0.1 [191]

4IMY [191]

[192]

AFF4-P-TEFb

0.01 [191]

4IMY [191]

[192]

AFF4-Tat-P-TEFb

0.0009 [191]

4OR5 [193]

None

AF9(AHD)-AF4

0.0002 [194]

2LM0 [194]

[195]

AF9(AHD)-DOT1L

0.0016 [194]

2MV7 [196]

[197]

ENL(AHD)-DOT1L

0.2 or 1.34 [198]

None

None

AF9 or ENL AHD-CBX8

 > 0.5 or 0.11 [199]

2N4Q [199]

None

AF9 or ENL AHD-BCoR

0.018 or 0.002 nM [199]

6B7G [199]

None

AF9(YEATS)-H3K9ac

3.7 [172]

4TMP [172]

[200,201,202,203,204]

ENL(YEATS)-H3K9ac

32.2 [205]

None

[200,201,202,203,204]

ENL(YEATS)-H3K27ac

30.5 [205]

5J9S [205]

[200,201,202,203,204]